Precision medicine,Medicine,Chinese traditional,Western medicine,Integrative medicine," /> Precision medicine,Medicine,Chinese traditional,Western medicine,Integrative medicine,"/>
Special Issue: Traditional Chinese Medicine
• Editorial • Next Articles
| 1 Mei T, Zhang Y, Hu S, Yang HM, Zhou Y.Construction of precision medicine system and its challenges.
2 Yang JF, Noffsinger A, Sreenarasimhaiah J, Yang Q.Mo1683 colorectal cancers with/without DNA mismatch repair defi ciency and tumor distribution patterns from 5 088 patients.
3 Yan W, Zhang A, Powell MJ.Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors.
4 Liontos M, Anastasiou I, Bamias A, Dimopoulos MA.DN A damage, tumor mutational load and their impact on immune responses against cancer.
5 Baek JH, Sun JM, Min YJ, Cho EK, Cho BC, Kim JH, Ahn MJ, Park K.Efficacy of EGFR tyrosine kinase inhibitors in patients with EG FR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: a retrospective analysis in Korea.
6 Jang SH.Long te rm therapeutic plan for patients with nonsmall cell lung cancer harboring EGFR mutation.
7 Anderson WF, Rosenberg PS, Katki HA.Tr acking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer.
8 Wong IO, Schooling CM, Cowling BJ, Leung GM.Br east cancer incidence and mortality in a transitioning Chinese population: current and future trends.
9 Recondo G Jr, de la Vega M, Galanternik F, Díaz-Cantón E, Leone BA, Leone JP. Nove l approaches to target HER2- positive breast cancer: trastuzumab emtansine.
10 Meers C, Keskin H, Storici F.DNA repair by RNA: templated, or not templated, that is the question.
11 Marshall E.Huma n genome 10th anniversary. Waiting for the revolution.
12 Editorial. Best is yet to come.
13 Check Hayden E.Huma n genome at ten: life is complicated.
14 National Research Council.Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Washington DC: National Academies Press. 2011.
15 Wu JR.Precision medicine based on systems biology.
16 16 Luo CS, Liu XJ. The problems we faced in development of precision medicine. (2015-06-10) [2016-08-10]. . The problems we faced in development of precision medicine. (2015-06-10) [2016-08-10]. http:// h.wokeji.com/jbsj/bb/201506/t20150610_1268749.shtml.
17 Yang GZ, Su XH, Wu XF, Dai XJ, Yang LY, Pan CZ.Association of single nucleotide polymorphisms in the proximal promoter region of the adiponectin gene with TCM syndromes in patients with type 2 diabetes.
18 Liu Q, Ling JY, Li XD, Zhang CZ, Song QL, Tan J, Huang J, Peng XM, Wang JP, Wu JH.Associations of rs3820998 polymorphism in TANK gene with syndrome types of TCM of hepatitis B related cirrhosis.
19 Shen ZY, Huang JH, Chen WH. Comparison of gene expression profiles between rats of Shen deficiency syndrome and Shen-yang defi ciency syndrome differentiated according to therapeutic effi cacy of drugs used.
20 Fan X, Shi M, Wang Y, Liang Q, Luo G.Tran scriptional profi ling analysis of HMP-treated rats with experimentally induced myocardial infarction.
21 Zhu H, Luo XP, Wang LJ, Li Y, Shi HM, Fan WH, Dai HR.Evaluation on clinical effect of long-term Shexiang Baoxin pill administration for treatment of coronary heart disease.
22 Luo XP, Li Y, Fan WJ, Zhang GF, Zhang J, Shi HM, Wang CP, Wang SY, Dai RH.Experimental study on reducing effect of Shexiang Baoxin pill from damage of arterial wall caused by hyperlipemia.
23 Zhang RX, Liu HJ. Treatment of unstable angina pectoris with Shexiang Baoxin pills combined with clopidogrel.
24 Gan L, Ling YJ, Zhu LP.Experience of the treatment of mild hypertension with increased low-density lipoprotein cholesterol.
25 Song KY, Wei YJ, Li LT.Effects of Shexiang Baoxin pills on coronary flow reserve in patients with slow coronary flow.
26 Shen W, Fan WH, Shi HM, Li Y, Luo XP, Zhang XL, Zhu J, Jin B, Li J, Pan JJ. Effects of Shexiang Baoxin pill on angiogenesis in atherosclerosis plaque and ischemic myocardium.
27 Chen Y, Fu DY, Chen Y, He YM, Fu XD, Xu YQ, Liu Y, Feng XT, Zhang T, Wang WJ.Effe cts of Chinese herbal medicine Yiqi Huaju Formula on hypertensive patients with metabolic syndrome: a randomized, placebo-controlled trial.
28 Wang TZ, Chen Y, He YM, Fu XD, Wang Y, Xu YQ, Yang HJ, Xue HL, Liu Y, Feng XT, Zhang T, Wang WJ.Effe cts of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial.
29 Zhang Z, Xue HL, Liu Y, Wang WJ.Yi-Qi-Zeng-Min-Tang, a Ch inese medicine, ameliorates insulin resistance in type 2 diabetic rats.
30 Feng XT, Wang TZ, Leng J, Chen Y, Liu JB, Liu Y, Wang WJ.Palm itate contributes to insulin resistance through down-regulation of the Src-mediated phosphorylation of Akt in C2C12 myotubes.
31 Feng X, Wang W, Liu J, Liu Y.β-Arrestins: multi functional signaling adaptors in type 2 diabetes.
32 Ya ng Q, Jia C, Wang P, Xiong M, Cui J, Li L, Wang W, Wu Q, Chen Y, Zhang T. MicroR NA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation.
33 Ga o S, Wang P, Hua Y, Xi H, Meng Z, Liu T, Chen Z, Liu L. ROR fu nctions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer.
34 Hu J, Qiu M, Jiang F, Zhang S, Yang X, Wang J, Xu L, Yin R.MiR-14 5 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells.
35 Yi JH, Shi WD, Liu LM.The recipe of Qingyi Huaji in treating advanced pancreatic cancer against expression of MMP-2.
36 Zhang JJ, Chen Z, Shi WD, Zhu XY, Liu LM.Effect of Qingyi Huaji Formula on serum immunosuppressive factors and immune function of splenic lymphocytes in mice with pancreatic cancer.
|||Brody Slostad, Tejinder Khalsa, Kathleen Young, Hildalicia Guerra, Anjali Bhagra. A case-based approach to integrative medicine for cardiovascular disease prevention. Journal of Integrative Medicine, 2020, 18(2): 159-162.|
|||Wen Qiang Lee, Jeremy Teoh, Pei Zheng Kenneth Lee, Zhi Xiong Gerard Low, Xueling Sim, Foong Fong Mary Chong, Norbert Ludwig Wagner. Factors influencing communication of traditional Chinese medicine use between patients and doctors: a multisite cross-sectional study. Journal of Integrative Medicine, 2019, 17(6): 396-403.|
|||Mohammad Hossein Ayati, Ata Pourabbasi, Nazli Namazi, Arman Zargaran, Zahra Kheiry, Amir Hooman Kazemi, Bagher Larijani. The necessity for integrating traditional, complementary, and alternative medicine into medical education curricula in Iran. Journal of Integrative Medicine, 2019, 17(4): 296-301.|
|||Mikhail Teppone. Medicine has always been “Modern” and “Scientific” from ancient times to the present day. Journal of Integrative Medicine, 2019, 17(4): 229-237.|
|||Tamer Aboushanab, Mohamed Khalil, YaserAl Ahmari. The present state of complementary medicine regulation in Saudi Arabia. Journal of Integrative Medicine, 2019, 17(3): 147-149.|
|||Hanae Naceiri Mrabti, Nidal Jaradat, Mohamed Reda Kachmar, Abdelaziz Ed-Dra, Abdelilah Ouahbi, Yahia Cherrah, Moulay El Abbes Faouzi. Integrative herbal treatments of diabetes in Beni Mellal region of Morocco. Journal of Integrative Medicine, 2019, 17(2): 93-99.|
|||Fung-Kei Cheng. An overview of the contribution of acupuncture to thyroid disorders. Journal of Integrative Medicine, 2018, 16(6): 375-383.|
|||Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248.|
|||Nian Huang. Integrative medicine is an evolving field and the future of healthcare: A summary of the 2017 Integrative Medicine Shanghai Forum. Journal of Integrative Medicine, 2018, 16(2): 71-71.|
|||Saswati Mahapatra, Anjali Bhagra, Bisrat Fekadu, Zhuo Li, Brent A. Bauer, Dietlind L. Wahner-Roedler. Incorporation of integrative medicine education into undergraduate medical education: A longitudinal study. Journal of Integrative Medicine, 2017, 15(6): 442-449.|
|||Xuan Liu, Li-juan Xiu, Jian-peng Jiao, Jing Zhao, Ying Zhao, Ye Lu, Jun Shi, Yong-jin Li, Min Ye, Yu-fang Gu, Xiao-wei Wang, Jing-yu Xu, Ci-an Zhang, Yong-ying Liu, Yun Luo, Xiao-qiang Yue. Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: A retrospective clinical analysis. Journal of Integrative Medicine, 2017, 15(6): 469-475.|
|||Andrian Liem, Kuncoro Dewi Rahmawati. The meaning of complementary, alternative and traditional medicine among the Indonesian psychology community: A pilot study. Journal of Integrative Medicine, 2017, 15(4): 288-294.|
|||Jin Yu, Chao-qin Yu, Qi Cao, Li Wang, Wen-jun Wang, Li-rong Zhou, Jing Li, Qiao-hong Qian. Consensus on the integrated traditional Chinese and Western medicine criteria of diagnostic classification in polycystic ovary syndrome (draft). Journal of Integrative Medicine, 2017, 15(2): 102-109.|
|||Razak Mohammed Gyasi, Adjoa Afriyie Poku, Simon Boateng, Padmore Adusei Amoah, Alhassan Abdul Mumin, Jacob Obodai, Williams Agyemang-Duah. Integration for coexistence? Implementation of intercultural health care policy in Ghana from the perspective of service users and providers. Journal of Integrative Medicine, 2017, 15(1): 44-55.|
|||Negoslav P. Ostojić, Silvia Saxer. Policies towards implementation of positive changes and the introduction of integrated health care for health systems. Journal of Integrative Medicine, 2016, 14(6): 409-411.|